Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02687386
What this trial is testing

Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR

Who this might be right for
Solid TumoursCNS Tumours
Dr David Ziegler 9
Testing effectiveness (Phase 2)Looking for participantsNCT07326566
What this trial is testing

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Black Diamond Therapeutics, Inc. 162
Testing effectiveness (Phase 2)Study completedNCT02917993
What this trial is testing

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Incyte Corporation 59
Not applicableUnknownNCT04030728
What this trial is testing

Implementing Patients´ Competence in Oral Breast Cancer Therapy

Who this might be right for
Metastatic Breast CancerAdvanced Breast Cancer
Onco Medical Consult GmbH 212
Testing effectiveness (Phase 2)Ended earlyNCT02770014
What this trial is testing

Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer

Who this might be right for
Epidermal Growth Factor ReceptorNon-Small Cell Lung Cancer
Dana-Farber Cancer Institute 43
Large-scale testing (Phase 3)Study completedNCT00327444
What this trial is testing

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Who this might be right for
Ovarian NeoplasmsAscites
Sanofi 58
Testing effectiveness (Phase 2)Looking for participantsNCT06845163
What this trial is testing

Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaCenter-involved Diabetic Macular Edema
Alexandria University 56
Not applicableNot Yet RecruitingNCT03390920
What this trial is testing

Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions

Who this might be right for
OsteoarthritisTendinitisSports Injury+5 more
R3 Stem Cell 200
Testing effectiveness (Phase 2)Looking for participantsNCT06202261
What this trial is testing

TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerRecurrent Breast CancerAdvanced Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 154
Testing effectiveness (Phase 2)Ended earlyNCT00503880
What this trial is testing

Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
University of Nebraska 2
Post-approval studies (Phase 4)Study completedNCT04724343
What this trial is testing

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

Who this might be right for
In Vitro FertilizationIntracytoplasmic Sperm InjectionInfertility
Damascus University 50
Not applicableLooking for participantsNCT05991193
What this trial is testing

A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer

Who this might be right for
NSCLC
Hunan Province Tumor Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT06417008
What this trial is testing

HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hansoh BioMedical R&D Company 1,080
Not applicableLooking for participantsNCT05356325
What this trial is testing

FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.

Who this might be right for
Fibroblast Growth Factor 23AnemiaCKD
Maimónides Biomedical Research Institute of Córdoba 401
Large-scale testing (Phase 3)UnknownNCT00185263
What this trial is testing

Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina

Who this might be right for
Stable Angina
Cardium Therapeutics 116
Testing effectiveness (Phase 2)Looking for participantsNCT05985655
What this trial is testing

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 230
Not applicableLooking for participantsNCT06278558
What this trial is testing

Psychological Factors Influencing Cancer Post-traumatic Growth

Who this might be right for
Cancer
Centre Hospitalier de Valenciennes 289
Not applicableNot Yet RecruitingNCT07733700
What this trial is testing

Cryotherapy, PGE2, NGF Levels and Pain After Endodontic Retreatment

Who this might be right for
Asymptomatic Apical PeriodontitisEndodontic RetreatmentCryotherapy
Alanya Alaaddin Keykubat University 100
Testing effectiveness (Phase 2)Study completedNCT03488108
What this trial is testing

Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women

Who this might be right for
Alopecia
Mayo Clinic 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 675
Next Page